Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma

Cholangiocarcinoma (CCA) is a highly malignant tumor of the hepatobiliary system that has failed to respond to many traditional therapies to a certain extent, including surgery, chemotherapy and radiotherapy. In recent years, the new therapeutic schemes based on immunology have fundamentally changed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li-ming, Shi, An-da, Yang, Yan, Liu, Zeng-li, Hu, Xiao-Qiang, Shu, Li-Zhuang, Tang, Yong-chang, Zhang, Zong-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090456/
https://www.ncbi.nlm.nih.gov/pubmed/37064120
http://dx.doi.org/10.3389/fonc.2023.1140103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090456/
https://www.ncbi.nlm.nih.gov/pubmed/37064120
http://dx.doi.org/10.3389/fonc.2023.1140103

Ejemplares similares